Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax. 2015;70(1):33–40. doi:10.1136/thoraxjnl-2014-205795
   PubMed Web of Science ®Google Scholar
• Wang M-T, Lo Y-W, Tsai C-L, et al. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med. 2013;126(7):598–606. doi:10.1016/j.amjmed.2013.01.036
   PubMed Web of Science ®Google Scholar
• Cao C, Wu Y, Xu Z, et al. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research. Sci Rep. 2015;5:16461. doi:10.1038/srep16461
   PubMed Web of Science ®Google Scholar
• Young R, Hopkins R, Eaton T. Pharmacological actions of statins: potential utility in COPD. Eur Respir Rev. 2009;18(114):222–232. doi:10.1183/09059180.00005309
   PubMedGoogle Scholar
• Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: a systematic review. Chest. 2009;136(3):734–743. doi:10.1378/chest.09-0194
   PubMed Web of Science ®Google Scholar
• Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm Med. 2009;9(1):32. doi:10.1186/1471-2466-9-32
   PubMedGoogle Scholar
• Lahousse L, Loth DW, Joos GF, et al. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther. 2013;26(2):212–217. doi:10.1016/j.pupt.2012.10.008
   PubMed Web of Science ®Google Scholar
• Lin C-M, Yang T-M, Yang Y-H, et al. Statin use and the risk of subsequent hospitalized exacerbations in COPD patients with frequent exacerbations. Int J Chron Obstruct Pulmon Dis. 2020;15:289. doi:10.2147/COPD.S229047
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Agusti A. Statins as adjunct therapy in COPD: how do we cope after STATCOPE? Thorax. 2014;69:891–894. doi:10.1136/thoraxjnl-2014-205814
   PubMed Web of Science ®Google Scholar
• Kalchiem-Dekel O, Reed RM. Statins in COPD: life after STATCOPE. Chest. 2017;152(3):456–457. doi:10.1016/j.chest.2017.04.156
   PubMed Web of Science ®Google Scholar
• Criner GJ, Connett JE, Aaron SD, et al. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med. 2014;370(23):2201–2210. doi:10.1056/NEJMoa1403086
   PubMed Web of Science ®Google Scholar
• Søyseth V, Brekke P, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J. 2007;29(2):279–283. doi:10.1183/09031936.00106406
   PubMed Web of Science ®Google Scholar
• Bartziokas K, Papaioannou AI, Minas M, et al. Statins and outcome after hospitalization for COPD exacerbation: a prospective study. Pulm Pharmacol Ther. 2011;24(5):625–631. doi:10.1016/j.pupt.2011.06.003
   PubMed Web of Science ®Google Scholar
• Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007;131(4):1006–1012. doi:10.1378/chest.06-1997
   PubMed Web of Science ®Google Scholar
• Neukamm A, Høiseth A, Einvik G, et al. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. Intern Med J. 2015;278(1):59–67. doi:10.1111/joim.12337
   Web of Science ®Google Scholar
• Balaguer C, Peralta A, Ríos Á, et al. Effects of simvastatin in chronic obstructive pulmonary disease: results of a pilot, randomized, placebo-controlled clinical trial. Contemp Clin Trials Commun. 2016;2:91–96. doi:10.1016/j.conctc.2015.12.008
   PubMedGoogle Scholar
• Zhang W, Zhang Y, Li C-W, Jones P, Wang C, Fan Y. Effect of statins on COPD: a meta-analysis of randomized controlled trials. Chest. 2017;152(6):1159–1168. doi:10.1016/j.chest.2017.08.015
   PubMed Web of Science ®Google Scholar
• André S, Conde B, Fragoso E, Boléo-Tomé J, Areias V, Cardoso J. COPD and cardiovascular disease. Pulmonology. 2019;25(3):168–176. doi:10.1016/j.pulmoe.2018.09.006
   PubMed Web of Science ®Google Scholar
• Beghé B, Verduri A, Roca M, Fabbri LM. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993–995. doi:10.1183/09031936.00180812
   PubMed Web of Science ®Google Scholar
• So JY, Dhungana S, Beros JJ, Criner GJ. Statins in the treatment of COPD and asthma—where do we stand? Curr Opin Pharmacol. 2018;40:26–33. doi:10.1016/j.coph.2018.01.001
   PubMed Web of Science ®Google Scholar
• Schmidt M, Cannegieter SC, Johannesdottir SA, Dekkers OM, Horváth-Puhó E, Sørensen HT. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study. J Thromb Haemost. 2014;12(8):1207–1215. doi:10.1111/jth.12604
   PubMed Web of Science ®Google Scholar
• Wallace A, Albadawi H, Hoang P, et al. Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S207. doi:10.21037/cdt.2017.09.12
   PubMedGoogle Scholar
• Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41(6):554–567. doi:10.1016/j.ctrv.2015.04.005
   PubMed Web of Science ®Google Scholar
• Hong K-S, Lee JS. Statins in acute ischemic stroke: a systematic review. J Stroke. 2015;17(3):282. doi:10.5853/jos.2015.17.3.282
   PubMed Web of Science ®Google Scholar
• Lee M, Saver JL, Wu YL, et al. Utilization of statins beyond the initial period after stroke and 1-year risk of recurrent stroke. J Am Heart Assoc. 2017;6(8):e005658. doi:10.1161/JAHA.117.005658
   PubMed Web of Science ®Google Scholar
• Valentino M, Al Danaf J, Panakos A, Ragupathi L, Duffy D, Whellan D. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke. Am Heart J. 2016;181:130–136. doi:10.1016/j.ahj.2016.07.024
   PubMed Web of Science ®Google Scholar
• Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2016;21(2):167–176. doi:10.1177/1074248415602557
   PubMed Web of Science ®Google Scholar
• Verrier RL. Statins protect against arrhythmogenic calcium alternans in the post–myocardial infarction diabetic heart: pleiotropy on steroids. Heart Rhythm. 2017;14(9):1417–1418. doi:10.1016/j.hrthm.2017.06.010
   PubMed Web of Science ®Google Scholar
• Kourliouros A, De Souza A, Roberts N, et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Cardiothorac Surg. 2008;85(5):1515–1520.
   Google Scholar
• Amarenco P, Labreuche J, Lavallée P, Touboul P-J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004;35(12):2902–2909. doi:10.1161/01.STR.0000147965.52712.fa
   PubMed Web of Science ®Google Scholar
• Ho T-W, Ruan S-Y, Huang C-T, Tsai Y-J, Lai F, Yu C-J. Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan. Int J Chron Obstruct Pulmon Dis. 2018;13:3055. doi:10.2147/COPD.S174265
   PubMed Web of Science ®Google Scholar